Expert Insights on Generics and Biosimilars

With health reform on the horizon, generics and biosimilars are at the forefront of the discussion. Will the US establish a pathway for these drugs? What are the hurdles?

Get expert insights on:

  • Future role of generic companies as pharma faces unprecedented patent expiration on blockbuster compounds
  • Manufacturing and regulatory hurdles for biosimilars
  • Role of CROs in the generics industry
  • Competitive pressure from generic manufacturers in India and China
Engage an Expert on Generics and Biosimilars

Gerson Lehrman Group Council Members are available to discuss Generics and Biosimilars via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Samir Mehta, Orthopaedic Surgeon, Hospital of the University of Pennsylvania - CC

Samir Mehta What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Orthopaedic SurgeonHospital of the University of Pennsylvania - CC

Michele Pauporte, Dermatologist, JUVA SKIN LASER CENTER INC

Michele Pauporte What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

DermatologistJUVA SKIN LASER CENTER INC

Kent Marquardt, EVP & CFO, PREMERA BLUE CROSS

Kent Marquardt What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

EVP & CFOPREMERA BLUE CROSS

Robert Dondes, Independent Consultant, Robert Dondes, Consultant

Robert Dondes What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Independent ConsultantRobert Dondes, Consultant

Hernan Fuenzalida-Puelma, Associate consultant, Sanigest Internacional S.A.

Hernan Fuenzalida-PuelmaWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Associate consultantSanigest Internacional S.A.

Browse all 364 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name No. Members
U.S. Department of Agriculture Experts: Legal, Economic, and Regulatory Affairs 27
Neurologists who Treat West Syndrome (Infantile Spasms) (US) 23
Parkinson's Disease Neurologists (US) 98
Rebif Prescribers for Multiple Sclerosis (US) 14
Zanaflex Prescribers for Spasticity (US) 34

Browse all 981 Study Groups

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

2 generic drugs - Imitrex and Eloxatin

August 16, 2009

GLG Expert Contributor

Browse all 8743 GLG News Analyses

Contact Gerson Lehrman Group to engage a Generics and Biosimilars expert